Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphoma

AIM: Autologous hematopoietic stem cell transplantation (ASCT) is the standard-of-care curative treatment for relapsed or refractory diffuse large B-cell lymphoma (RR-DLBCL), but the relapse rate is usually high. MATERIALS & METHODS: In this study, we treated 14 RR-DLBCL patients by combining AS...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Immunotherapy
Auteurs principaux: Wang, Tao, Gao, Lei, Wang, Yujie, Zhu, Wenjun, Xu, Lili, Wang, Yang, Yue, Wenqin, Tang, Gusheng, Chen, Li, Chen, Jie, Zhang, Weiping, Yu, Xuejun, Feng, Dongge, Yang, Jianmin
Format: Artigo
Langue:Inglês
Publié: Future Medicine Ltd 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7546158/
https://ncbi.nlm.nih.gov/pubmed/32752910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0075
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires